Accelerating Clinical Trial Entry: Tailoring Modality-Specific- MIDD Strategies for Maximum Efficiency in ADC & TCE trials
Time: 12:00 pm
day: Day 1
Details:
- Hear advice on designing modality-specific approaches where strategic plans were uniquely differed for contrasting modalities
- Learn the type of in vitro and in vivo data required for translational modeling for FIH dose selection for ADCs and TCEs
- Gain insights from case studies where this tailoring approach has enabled acceleration of clinical trials
